Bayesian Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,546
| Closed | -$339K | – | 647 |
|
|
2025
Q2 | $339K | Buy |
+4,546
| New | +$301K | 0.05% | 370 |
|
|
2024
Q4 | – | Sell |
-4,033
| Closed | -$324K | – | 809 |
|
|
2024
Q3 | $324K | Sell |
4,033
-1,200
| -23% | -$96.9K | 0.04% | 459 |
|
|
2024
Q2 | $433K | Buy |
+5,233
| New | +$460K | 0.05% | 414 |
|
|
2023
Q1 | – | Sell |
-7,143
| Closed | -$562K | – | 913 |
|
|
2022
Q4 | $562K | Buy |
7,143
+3,600
| +102% | +$289K | 0.08% | 319 |
|
|
2022
Q3 | $262K | Buy |
+3,543
| New | +$254K | 0.05% | 455 |
|
|
2022
Q2 | – | Sell |
-7,694
| Closed | -$486K | – | 899 |
|
|
2022
Q1 | $486K | Buy |
+7,694
| New | +$418K | 0.07% | 377 |
|
|
2021
Q3 | – | Sell |
-7,500
| Closed | -$500K | – | 449 |
|
|
2021
Q2 | $500K | Buy |
+7,500
| New | +$531K | 0.13% | 190 |
|
|
2020
Q3 | – | Sell |
-5,700
| Closed | -$510K | – | 586 |
|
|
2020
Q2 | $510K | Buy |
5,700
+1,300
| +30% | +$131K | 0.11% | 238 |
|
|
2020
Q1 | $439K | Sell |
4,400
-3,300
| -43% | -$358K | 0.09% | 329 |
|
|
2019
Q4 | $885K | Buy |
7,700
+4,200
| +120% | +$508K | 0.15% | 196 |
|
|
2019
Q3 | $441K | Buy |
+3,500
| New | +$444K | 0.08% | 301 |
|
|
2019
Q1 | – | Sell |
-7,254
| Closed | -$726K | – | 636 |
|
|
2018
Q4 | $726K | Buy |
7,254
+2,900
| +67% | +$305K | 0.15% | 209 |
|
|
2018
Q3 | $499K | Sell |
4,354
-10,300
| -70% | -$1.07M | 0.08% | 338 |
|
|
2018
Q2 | $1.31M | Buy |
14,654
+5,654
| +63% | +$477K | 0.3% | 84 |
|
|
2018
Q1 | $658K | Sell |
9,000
-3,700
| -29% | -$254K | 0.17% | 205 |
|
|
2017
Q4 | $738K | Buy |
+12,700
| New | +$669K | 0.15% | 232 |
|
|
2017
Q1 | – | Sell |
-10,023
| Closed | -$403K | – | 517 |
|
|
2016
Q4 | $403K | Buy |
+10,023
| New | +$378K | 0.1% | 352 |
|
Other funds holding HAE
RRAM
